Skip to content

Safety Study of Analgesia After Craniotomy Surgery With End Tidal (ET) Carbon Dioxide (CO2) Monitoring

Post Craniotomy Analgesia Safety Monitoring With ET CO2

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01327677
Enrollment
137
Registered
2011-04-01
Start date
2011-05-31
Completion date
2014-05-31
Last updated
2017-05-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain

Keywords

pain management, opioid analgesic therapy, safety, craniotomy

Brief summary

This research is being done to compare two methods of giving fentanyl, a narcotic often given to patients following brain surgery and determine if one method has more side effects than the other. Both of these methods are available in the postoperative treatment of pain. This research also is being done to determine if patients receiving narcotic pain medicine will benefit from additional monitoring of carbon dioxide levels. Since narcotic pain medicines can slow down breathing, The investigators want to see if measuring exhaled carbon dioxide levels will help identify a slower breathing rate and improve safety.

Detailed description

See brief summary

Interventions

DRUGFentanyl

25-50 mcg every 20 minutes

Sponsors

Johns Hopkins University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Adult male and female, English speaking patients undergoing supratentorial craniotomy for tumor under general anesthesia at the Johns Hopkins Hospital will be eligible for this study.

Exclusion criteria

* pregnant women * patients with post operative neurological changes * patients who remain intubated post-operatively * patients who require the use of concomitant administration of sedatives * patients who are unable to initiate a PCA bolus * patients who are unable to communicate verbally * patients who are allergic to fentanyl * patients who have a history of narcotic abuse * patients who have a history of chronic pain requiring opioids * patients who have been in any investigational drug trial within 1 month of the treatment day * patients who have chronic respiratory insufficiency

Design outcomes

Primary

MeasureTime frameDescription
Respiratory Depressionup to 24 hours postoperativelyDefined by minimum respiratory rate (breaths/minute).

Secondary

MeasureTime frameDescription
Hypoxiaup to 24 hours postoperativelyDefined by minimum oxygen saturation (SaO2)

Other

MeasureTime frameDescription
Mean Fentanyl Consumptionup to 24 hours postoperativelyAmount of cumulative fentanyl consumed in mcg

Countries

United States

Participant flow

Participants by arm

ArmCount
PRN Fentanyl
A nurse can administer up to 3 doses of fentanyl intravenously (through a vein) each hour whenever a patient indicates that he or she is in pain. Fentanyl: 25-50 mcg every 20 minutes
48
IVPCA Fentanyl
A patient can self-administer fentanyl intravenously with a Patient Controlled Analgesia (PCA) pump. Fentanyl: 20mcg/demand dose with an 8 minute lock out
56
Total104

Baseline characteristics

CharacteristicIVPCA FentanylTotalPRN Fentanyl
Age, Continuous50.4 years
STANDARD_DEVIATION 13.7
49.8 years
STANDARD_DEVIATION 13.8
49.1 years
STANDARD_DEVIATION 14
Race/Ethnicity, Customized
Black
7 Participants12 Participants5 Participants
Race/Ethnicity, Customized
Other
5 Participants6 Participants1 Participants
Race/Ethnicity, Customized
White
44 Participants86 Participants42 Participants
Sex: Female, Male
Female
25 Participants51 Participants26 Participants
Sex: Female, Male
Male
31 Participants53 Participants22 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 480 / 56
other
Total, other adverse events
0 / 480 / 56
serious
Total, serious adverse events
0 / 480 / 56

Outcome results

Primary

Respiratory Depression

Defined by minimum respiratory rate (breaths/minute).

Time frame: up to 24 hours postoperatively

ArmMeasureValue (MEAN)Dispersion
PRN FentanylRespiratory Depression10.9 breaths/minuteStandard Error 0.4
PCA FentanylRespiratory Depression10.5 breaths/minuteStandard Error 0.4
Primary

Respiratory Depression

Defined by maximal End Tidal CO2 (mmHg)

Time frame: Up to 24 hours postoperatively.

ArmMeasureValue (MEAN)Dispersion
PRN FentanylRespiratory Depression41.4 mmHgStandard Error 0.6
PCA FentanylRespiratory Depression41.1 mmHgStandard Error 0.7
Secondary

Hypoxia

Defined by minimum oxygen saturation (SaO2)

Time frame: up to 24 hours postoperatively

ArmMeasureValue (MEAN)Dispersion
PRN FentanylHypoxia95.8 Percent Oxygen SaturationStandard Error 0.2
PCA FentanylHypoxia96.3 Percent Oxygen SaturationStandard Error 0.2
Other Pre-specified

Mean Fentanyl Consumption

Amount of cumulative fentanyl consumed in mcg

Time frame: up to 24 hours postoperatively

ArmMeasureValue (MEAN)Dispersion
PRN FentanylMean Fentanyl Consumption16.5 micrograms/ hourStandard Error 2.65
PCA FentanylMean Fentanyl Consumption26.4 micrograms/ hourStandard Error 2.5

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026